Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Study may lead to new insights on use of aspirin in GI cancer

Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients with tumours in different GI locations have been analysed at the same time; previously, only one type of cancer, usually colorectal, was studied.

28 Sep 2015

Re-engineering the brain to perceive food differently

Can we make people healthier by tricking the brain into thinking broccoli tastes like chocolate? A group of internationally acclaimed chefs, bench neuroscientists, food scientists and clinical neurologists are confident that they can.

26 Sep 2015

Ocean cells contribute to contextual learning process, shows research

When we misplace something, retracing our steps often helps us remember where we put it because environmental contexts are strongly linked to memory formation.

26 Sep 2015

Comprehensive collection of human genomic variants now available in Kaviar database

The Institute for Systems Biology (ISB) and the Inova Translational Medicine Institute (ITMI) announced today a new release of Kaviar, the most comprehensive collection of human genomic variants currently available to the public.

26 Sep 2015

Scripps becomes first health care provider in San Diego County to implant Evera MRI SureScan ICD System

Scripps Health is the first health care provider in San Diego County to use the only implantable cardioverter defibrillator (ICD) device approved for use with magnetic resonance imaging (MRI) scans.

26 Sep 2015

Inflammatory response could be key link between dietary fats and obesity-related diseases

An enhanced inflammatory response could be the key link between high saturated fat intake - a recognized risk factor for obesity-related disorders - and the development of diseases like type 2 diabetes and atherosclerosis.

26 Sep 2015

TUM scientists develop molecules that could pave way for new treatments to fight Alzheimer's, diabetes

When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and 'protein aggregation' processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.

26 Sep 2015

New study heightens concerns over detrimental impact of air pollution on gene associated with AD risk

A new study by researchers at the Universities of Montana, Valle de México, Boise State, and North Carolina, the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, and Centro Médico Cozumel heightens concerns over the detrimental impact of air pollution on hippocampal metabolites as early markers of neurodegeneration in young urbanites carrying an allele 4 of the apolipoprotein E gene (APOE).

26 Sep 2015

Lumbar puncture well-accepted by memory clinic patients

Researchers support the increasing use of lumbar punctures (LPs) by memory clinics to collect cerebrospinal fluid, as long as certain risk factors are taken into account.

25 Sep 2015

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Resverlogix Corp. announced today the commencement of an Orphan Disease Program specific for Complement Mediated Diseases. New data generated by Resverlogix has demonstrated that BET inhibition by apabetalone (RVX-208) has effects on multiple biological pathways that underlie disease pathology.

24 Sep 2015

Dextromethorphan–quinidine promising for agitation in Alzheimer’s patients

The combination of dextromethorphan hydrobromide and quinidine sulphate shows promising efficacy against agitation in a phase 2 trial in patients with Alzheimer’s disease.

23 Sep 2015

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

23 Sep 2015

Findings may suggest new therapeutic target to combat memory loss in aging, Alzheimer's disease

Northwestern Medicine scientists have examined activity in a little-studied part of the brain associated with memory and found for the first time the reason that neurons there become more active in old age, findings that may suggest a new target for future therapies to combat memory loss in aging and Alzheimer's disease.

23 Sep 2015

NJIT President Joel Bloom to be honored as Educator of the Year

The Research & Development Council of New Jersey will honor the winners of the 2015 Edison Patent Awards at the 36th Edison Patent Awards Ceremony & Reception on November 12, 2015. Over 50 inventors and 12 New Jersey companies and universities will be recognized at the event.

23 Sep 2015

Amyloid PET method works well for detecting early signs of Alzheimer's disease

A method for detecting early signs of Alzheimer's disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. This is the conclusion of a new Lund University study - the most thorough and extensive undertaken in the field so far.

23 Sep 2015

Brain health: how can you reduce cognitive decline? An interview with Heather Snyder, Ph.D.

Reader’s Digest and the Alzheimer’s Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.

22 Sep 2015

Study analyzes psychological stress of family caregivers following Alzheimer's diagnosis

Caregiving for an Alzheimer's patient is especially burdensome for spousal and family caregivers who at the time of their near and dear one's Alzheimer's diagnosis suffer from depressive symptoms, according to a recent University of Eastern Finland study.

22 Sep 2015

New study looks at how remote conditioning can help reduce dementia

A new study is looking at whether short, daily bouts of reduced blood flow to an arm or leg can reduce the ravages of dementia.

22 Sep 2015

Salsalate drug offers new hope for treating Alzheimer's disease and FTD

Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal dementia (FTD). Salsalate prevented the accumulation of tau in the brain and protected against cognitive impairments resembling impairments seen in Alzheimer's disease and FTD.

21 Sep 2015

$Common Alzheimer's disease drug increases bone density, reduces fracture risks$

Common Alzheimer's disease drug increases bone density, reduces fracture risks

The most common drug used to treat Alzheimer's disease increases bone mass in mice, according to one of the first research articles published in the new open access journal Heliyon. The authors of the study, from Saitama Medical University in Japan, say this means the drug could also be used to treat bone loss diseases like osteoporosis and periodontitis, following further clinical research.

21 Sep 2015

Alzheimer's Disease News and Research

Further Reading

Study may lead to new insights on use of aspirin in GI cancer

Re-engineering the brain to perceive food differently

Ocean cells contribute to contextual learning process, shows research

Comprehensive collection of human genomic variants now available in Kaviar database

Scripps becomes first health care provider in San Diego County to implant Evera MRI SureScan ICD System

Inflammatory response could be key link between dietary fats and obesity-related diseases

TUM scientists develop molecules that could pave way for new treatments to fight Alzheimer's, diabetes

New study heightens concerns over detrimental impact of air pollution on gene associated with AD risk

Lumbar puncture well-accepted by memory clinic patients

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Dextromethorphan–quinidine promising for agitation in Alzheimer’s patients

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

Findings may suggest new therapeutic target to combat memory loss in aging, Alzheimer's disease

NJIT President Joel Bloom to be honored as Educator of the Year

Amyloid PET method works well for detecting early signs of Alzheimer's disease

Brain health: how can you reduce cognitive decline? An interview with Heather Snyder, Ph.D.

Study analyzes psychological stress of family caregivers following Alzheimer's diagnosis

New study looks at how remote conditioning can help reduce dementia

Salsalate drug offers new hope for treating Alzheimer's disease and FTD

Common Alzheimer's disease drug increases bone density, reduces fracture risks

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News